March 2, 2015
Survival and recurrence rates were unaffected by HIV infection among patients who underwent liver transplantation for hepatocellular carcinoma, according to a poster presentation at CROI 2015.
In this prospective cohort study, 74 patients with HIV and HCC who underwent liver transplantation across 22 clinical centers in Spain were matched in a 1:3 ratio with 222 non–HIV-infected patients with HCC who underwent liver transplantation to determine whether HIV infection affected survival or recurrence rates for HCC after liver transplantation. Of all the patients, 86% were men and 92% had hepatitis C virus infection. At the time of liver transplantation, 96% of patients with HIV were undergoing antiretroviral therapy. Median follow-up was 46 months.